Japan Regulatory Strategy Manager
Amgen
Japan Regulatory Strategy Manager
Amgen
Makes biotech medicines for serious illnesses
HOW MIGHT YOU DEFY IMAGINATION?
Amgen is a global leader in biotechnology with a history of more than four decades of pioneering breakthroughs. Our commitment to science has led us to discover and develop innovative therapies that significantly improve patients' lives. We also invest in cutting-edge manufacturing and support services to deliver these therapies worldwide. Japan and the Asia Pacific (JAPAC) region represent the fastest-growing area for Amgen. We are currently seeking a qualified candidate for the role of Japan Regulatory Strategy Manager (Regulatory Affairs Mgr).
What you will do:
Japan Regulatory Affairs provides leadership, expertise, and execution for the regulatory strategy to obtain and maintain clinical trial and marketing licenses for Amgen molecules in Japan in alignment with local business priorities and global regulatory strategy.
Main Responsibilities
Key Activities
Strategy and Execution
Communication and Collaboration
Health Authority (HA) Interaction
External Interactions
Compliance
Basic
Preferred
Knowledge and Skills
What you can expect of us:
As we work to develop treatments that take care of others, so we work to care for our teammates’ professional and personal growth and well-being.
In our quest to serve patients above all else, Amgen is the first to imagine, and the last to doubt. Join us.
careers.amgen.com
Amgen is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
We will ensure that individuals with disabilities are provided a reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request an accommodation.
Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.
Explore more opportunities at Amgen